实用老年医学 ›› 2025, Vol. 39 ›› Issue (9): 924-928.doi: 10.3969/j.issn.1003-9198.2025.09.013

• 临床研究 • 上一篇    下一篇

17例老年肺放线菌感染病人临床特征分析

张宁, 高秀, 康琳, 刘晓红   

  1. 100730 北京市,中国医学科学院北京协和医院老年医学科(张宁,康琳,刘晓红);719000 陕西省榆林市,榆林市第一医院全科医学科(高秀)
  • 收稿日期:2025-01-05 出版日期:2025-09-20 发布日期:2025-09-19
  • 通讯作者: 康琳,Email: kanglin_66@126.com
  • 基金资助:
    中央高水平医院临床科研专项(2022-PUMCH-B-129)

Analysis of clinical characteristics of 17 elderly patients with pulmonary actinomycosis

ZHANG Ning, GAO Xiu, KANG Lin, LIU Xiaohong   

  1. Department of Geriatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China (ZHANG Ning, KANG Lin, LIU Xiaohong); Department of General Medicine, the First Hospital of Yulin City, Yulin 719000, China (GAO Xiu)
  • Received:2025-01-05 Online:2025-09-20 Published:2025-09-19
  • Contact: KANG Lin, Email:kanglin_66@126.com

摘要: 目的 总结老年人肺放线菌感染的临床特征,以提高诊治水平。 方法 回顾性分析2014年1月至2024年5月北京协和医院17例老年肺放线菌感染病人的临床资料。 结果 本研究中男9例,女8例,确诊中位年龄为67岁。中位年龄校正查尔森共病指数(aCCI)4分,13例存在全身危险因素(糖尿病、免疫抑制等),4例有局部危险因素(牙周疾病等)。16例出现临床症状,包括咳嗽(12例)、发热(10例)、咳痰(8例)及咯血(5例)。实验室检查:5例WBC升高(>9.5×109/L),8例hs-CRP>8 mg/L,9例红细胞沉降率(ESR)>20 mm/h。胸部CT表现以团块/结节影(7例)和空洞影(4例)为主。病原学确诊途径:合格痰培养(7例)、支气管镜标本培养(7例)、组织活检(2例)及胸腔积液培养(1例)。治疗方面,12例接受静脉滴注抗生素(10例使用青霉素类),8例口服青霉素类药物,12例联合应用≥2种抗生素。中位随访5.6年,15例治愈,2例死亡。 结论 老年肺放线菌感染病人多伴基础疾病,临床表现以呼吸道症状为主,影像学特征以团块/空洞病变为主。支气管镜及痰标本培养阳性率较高,青霉素类药物联合治疗预后良好。建议临床对存在危险因素的老年呼吸道感染病人进行放线菌病鉴别诊断。

关键词: 老年人, 肺放线菌病, 临床特征

Abstract: Objective To summarize the clinical characteristics of pulmonary actinomycosis in the elderly patients, and to improve the levels of diagnosis and treatment. Methods A retrospective analysis was conducted on the clinical data of 17 elderly inpatients with pulmonary actinomycosis at Peking Union Medical College Hospital from January 2014 to May 2024. Results Among the patients, 9 cases were male and 8 cases were female, with a median age at diagnosis of 67 years. The median age-adjusted Charlson Comorbidity Index (aCCI) was 4 points, with 13 patients presenting with systemic risk factors such as diabetes and immunosuppression, and 4 patients presenting with local risk factors such as periodontal disease. Clinical symptoms were observed in 16 patients, including cough (12 cases), fever (10 cases), sputum production (8 cases), and hemoptysis (5 cases). Laboratory tests revealed that 5 cases showed white blood cell count >9.5×109/L, 8 cases had high sensitivity C-reactive protein (hs-CRP) level >8 mg/L, and 9 cases had erythroayte sedimentation rate (ESR) value>20 mm/h. Chest CT predominantly displayed mass/nodular shadows (7 cases) and cavitary shadows (4 cases). Etiological confirmation pathways included qualified sputum culture (7 cases), bronchoscopic specimen culture (7 cases), tissue biopsy (2 cases), and pleural effusion culture (1 case). In terms of treatment, 12 cases received intravenous antibiotics (10 cases utilized penicillin), 8 cases were treated with oral penicillin, and 12 cases underwent treatment with a combination of ≥2 antibiotics. The median follow-up duration was 5.6 years, with 15 cases achieving cure and 2 cases resulting in death. Conclusions Pulmonary actinomycosis in the elderly is frequently associated with underlying diseases, with clinical manifestations primarily consisting of respiratory symptoms. Imaging features are mainly characterized by mass/cavitary lesions. The positive rate of bronchoscopy and sputum culture is relatively high, and the prognosis is favorable with penicillin-based combination therapy. It is suggested that actinomycosis should be differentiated in elderly patients with respiratory tract infection with risk factors.

Key words: aged, pulmonary actinomycosis, clinical characteristic

中图分类号: